TABLE 2 (continued)
1
2
3
3.10 (2H, m, CH2); 5.58 (1H, m, SCH2CH); 6.46 (1H, m, CH);
7.44 (7H, m, ArH); 7.74 (1H, m, ArH); 8.16 (1H, m, ArH)
1710*
7b
8а
8b
9
3.26 (2H, m, CH2); 5.59 (1H, m, SCH2CH); 6.44 (1H, m, CH):
1660*
1650*
1655*
7.44 (7H, m, ArH); 7.67 (1H, m, ArH); 8.09 (1H, m, ArH)
3.04 (2H, m, CH2); 5.56 (1H, m, SCH2CH); 6.38 (1H, m, CH);
7.46 (7H, m, ArH); 7.68 (1H, m, ArH); 8.09 (1H, m, ArH)
6.49 (1H, dd, J = 6.6 and J = 9.7, SCH=CH); 6,71 (1H, d, J = 9.7,
SCH=CH); 6.90 (1H, d, J = 6.6, CH); 7.28-7.35 (5H, m, ArH);
7.50 (1H, m, ArH); 7.72-7.81 (2H, m, ArH); 8.09 (1H, m, ArH)
4.07 (3H, m, CH2–CH); 6.24 (1H, m, CH); 7.22-7.45 (7H, m, ArH);
1650*
1650*
1650*
10а
10b
12
7.61-7.69 (1H, m, ArH); 8.07 (1H, m, ArH)
3.93 (3H, m, CH2–CH); 6.13 (1H, m, CH); 7.23-7.44 (7H, m, ArH);
7.65 (1H, m, ArH); 8.07 (1H, m, ArH)
2.14 (3H, s, CH3); 6.62 (1H, m, ArH); 7.35 (1H, m, ArH);
7.45 (1H, m, ArH); 7.56-7.64 (5H, m, ArH); 8.17 (1H, m, ArH)
_______
* (C=O of the quinazoline unit).
*2 (C=O of the carbethoxy unit).
EXPERIMENTAL
1
IR spectra of KBr tablets were recorded with a UR-10 instrument. H NMR spectra of DMSO-d6
solutions with TMS as internal standard were recorded on a Varian VXR (300 MHz) machine.
2-(3-Phenyl-2-propenylthio)-4(3H)-quinazolinone (2). Cinnamyl chloride (3.1 g, 20 mmol) was
added to a solution of compound 1 (4.32 g, 20 mmol) in a mixture of ethanol (80 ml) and water (20 ml) and the
mixture was boiled for 60-70 min. The quinazolinone 2 which crystallized was filtered off, washed with water
heated to 35-40°C (40 ml), and then with ethanol and ether. It was recrystallized from a 4:1 mixture of ethanol
and dioxane.
Reaction of Compound 1 with Ethyl 4-Bromocrotonate 3. A. Compound 1 (1.08 g, 5 mmol) was
added to a mixture of ethanol (30 ml) and water (2 ml) and heated with stirring until the solid dissolved. The
solution was cooled to 10-15°C and kept at that temperature while compound 3 (1.0 g, 6 mmol) was added
dropwise with vigorous stirring. After 20 h the precipitate was filtered off and washed with water and ethanol to
1
give a white microcrystalline substance (1.33 g) which consisted (from the data of H NMR spectroscopy) of
45% of compound 6 and 55% of 3-carboethoxymethyl-2,3-dihydro-5H-thiazolo[2,3-b]quinazolin-5-one (5).
Both compounds were obtained pure by fractional crystallization from ethanol.
B. 1-Carboethoxymethyl-1,2-dihydrothiazolo[3,2-a]quinazol-5-one (6). Compound 1 (1.08 g,
5 mmol) was dissolved in a mixture of ethanol (20 ml) and water (10 ml). Compound 3 (1.0 ml, 6 mmol) was
then added. The mixture was boiled for 1 h, the precipitate which formed was filtered off, washed with water
heated to 30-40°C, and then with ethanol and ether. It was crystallized from ethanol.
a
2-Bromo-6-oxo-1-phenyl-1,2-dihydro-3H,5H-[1,3]thiazino[3,2- ]quinazolinium Tribromide (7a).
A solution of bromine (0.16 ml, 3 mmol) in acetic acid (15 ml) was added dropwise over 30-40 min with
intermittent stirring to a suspension of compound 2 (0.441 g, 1.5 mmol) in glacial acetic acid (35 ml). The
reaction temperature remained at 15-18°C. The orange microcrystalline precipitate which separated over 8-10 h
was filtered off, washed with acetic acid and ether, and dried in a vacuum desiccator over P2O5.
a
2-Iodo-6-oxo-1-phenyl-1,2-dihydro-3H,5H-[1,3]thiazino[3,2- ]quinazolinium Pentaiodide (7b).
Compound 2 (0.441 g, 1.5 mmol) was dissolved on heating in glacial acetic acid (40 ml). The solution was
cooled to 20°C and iodine (1.14 g, 4.5 mmol) in acetic acid (100 ml) was added dropwise over 1 h with
643